An Irish company is using four American diamondback rattlesnakes in a new clinical trial that will test snake venom as a treatment for cancer. The snakes, which hail from the Albuquerque BioPark, will be allowed to bite something and have their venom extracted humanely. The venom contains proteins that will be extracted and refined to target and kill cancer cells.
Snake venom has long shown promise as a treatment for cancer, in a wide range of animal trials dating back several years. Celtic Biotech isolated a protein in a type of rattlesnake venom that causes malignant cancer cells to commit cell suicide.
Photo by Charles & Clint.
With 2,000 locations open or in development in 15 countries, Snap Fitness is the top choice
Thin Energy is looking for a limited number of motivated business minded people
Jamberry Nails signature product, Jamberry Nail Shields, which are essentially stick-on nail art
Can we solve the #1 Business problem people have today? Yes -- and the answer is simple...
PromoSlam has a mission to develop real solutions for individuals and families